MIST (STOCKS)
Milestone Pharmaceuticals Inc. Common Shares
$1.350000
+0.080000 (+6.30%)
Prev close: $1.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph G. Oliveto
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $163.71M
- Employees
- 33
- P/E (TTM)
- -1.92
- P/B (TTM)
- 4.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.20 | $0.31 | -0.5128 | -163.94% |
|
Dec 2025 (Q4)
|
$-0.18 | $-0.16 | -0.0168 | -10.29% |
|
Sep 2025 (Q3)
|
$-0.12 | $-0.17 | +0.0473 | +28.27% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.18 | -0.0189 | -10.44% |
Financial Statements
| Research and Development | $16.38M |
| Operating Income/Loss | -$65.28M |
| Income/Loss From Continuing Operations After Tax | -$68.36M |
| Income/Loss From Continuing Operations Before Tax | -$68.36M |
| Net Income/Loss | -$68.36M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$68.36M |
| Net Income/Loss Available To Common Stockholders, Basic | -$68.36M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.67 |
| Diluted Earnings Per Share | -$0.67 |
| Assets | $193.73M |
| Current Assets | $192.25M |
| Cash | $184.20M |
| Inventory | $1.83M |
| Prepaid Expenses | $1.21M |
| Other Current Assets | $5.02M |
| Noncurrent Assets | $1.48M |
| Fixed Assets | $500.00K |
| Other Non-current Assets | $981.00K |
| Liabilities | $157.69M |
| Current Liabilities | $20.94M |
| Accounts Payable | $10.02M |
| Wages | $1.15M |
| Other Current Liabilities | $9.77M |
| Noncurrent Liabilities | $136.74M |
| Long-term Debt | $58.19M |
| Other Non-current Liabilities | $78.55M |
| Equity | $36.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $36.05M |
| Liabilities And Equity | $193.73M |
| Net Cash Flow From Operating Activities | -$51.14M |
| Net Cash Flow From Operating Activities, Continuing | -$51.14M |
| Net Cash Flow From Investing Activities | -$102.37M |
| Net Cash Flow From Investing Activities, Continuing | -$102.37M |
| Net Cash Flow From Financing Activities | $179.74M |
| Net Cash Flow From Financing Activities, Continuing | $179.74M |
| Net Cash Flow | $26.23M |
| Net Cash Flow, Continuing | $26.23M |
| Comprehensive Income/Loss | -$68.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.36M |
| Other Comprehensive Income/Loss | $0.00 |